Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Nuo Therapeutics, Inc.Financial_Report.xls
EX-31.1 - EXHIBIT 31.1 - Nuo Therapeutics, Inc.v409465_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - Nuo Therapeutics, Inc.v409465_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - Nuo Therapeutics, Inc.v409465_ex32-1.htm
10-Q - FORM 10-Q - Nuo Therapeutics, Inc.v409465_10q.htm

 

Exhibit 32.2

 

Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

Pursuant to 18 U.S.C. §1350 and in connection with the Quarterly Report on Form 10-Q of Nuo Therapeutics, Inc. (the “Company”) for the period ended March 31, 2015 (the “Report”), I, Steven A. Shallcross, Chief Financial Officer of the Company, hereby certify, that, to my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

  Date: May 14, 2015 /s/ Steven A. Shallcross
   

Steven A. Shallcross

Chief Financial Officer

    (Principal Financial Officer)